GLP‐1 suppresses glucagon secretion in human pancreatic alpha‐cells by inhibition of P/Q‐type Ca(2+) channels

Glucagon is the body's main hyperglycemic hormone, and its secretion is dysregulated in type 2 diabetes mellitus (T2DM). The incretin hormone glucagon‐like peptide‐1 (GLP‐1) is released from the gut and is used in T2DM therapy. Uniquely, it both stimulates insulin and inhibits glucagon secretio...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramracheya, Reshma, Chapman, Caroline, Chibalina, Margarita, Dou, Haiqiang, Miranda, Caroline, González, Alejandro, Moritoh, Yusuke, Shigeto, Makoto, Zhang, Quan, Braun, Matthias, Clark, Anne, Johnson, Paul R., Rorsman, Patrik, Briant, Linford J. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125244/
https://www.ncbi.nlm.nih.gov/pubmed/30187652
http://dx.doi.org/10.14814/phy2.13852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125244/
https://www.ncbi.nlm.nih.gov/pubmed/30187652
http://dx.doi.org/10.14814/phy2.13852

Ejemplares similares